| 0 |
DIABETIC WOUND |
1 |
0.0108 |
| 1 |
ALCOHOL PROBLEM |
1 |
0.0041 |
| 2 |
WOUND SEPSIS |
1 |
0.0035 |
| 3 |
GALLBLADDER CHOLESTEROLOSIS |
1 |
0.0022 |
| 4 |
APPLICATION SITE ACNE |
1 |
0.0020 |
| 5 |
FOCAL NODULAR HYPERPLASIA |
1 |
0.0019 |
| 6 |
WHITE COAT HYPERTENSION |
1 |
0.0018 |
| 7 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 8 |
URINARY TRACT INFECTION FUNGAL |
1 |
0.0017 |
| 9 |
MALIGNANT ASCITES |
1 |
0.0013 |
| 10 |
QRS AXIS ABNORMAL |
1 |
0.0013 |
| 11 |
TRANSPOSITION OF THE GREAT VESSELS |
1 |
0.0013 |
| 12 |
ACNE PUSTULAR |
1 |
0.0012 |
| 13 |
VULVOVAGINAL ERYTHEMA |
1 |
0.0012 |
| 14 |
PILOERECTION |
1 |
0.0009 |
| 15 |
EMBOLISM ARTERIAL |
1 |
0.0008 |
| 16 |
LIP DISCOLOURATION |
1 |
0.0008 |
| 17 |
SKIN WRINKLING |
2 |
0.0007 |
| 18 |
DIABETIC FOOT INFECTION |
1 |
0.0007 |
| 19 |
HYPOAESTHESIA FACIAL |
1 |
0.0007 |
| 20 |
VASCULAR RUPTURE |
1 |
0.0006 |
| 21 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 22 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 23 |
GALLBLADDER INJURY |
1 |
0.0005 |
| 24 |
MEDICAL DEVICE PAIN |
1 |
0.0005 |
| 25 |
TONGUE DISCOLOURATION |
2 |
0.0005 |
| 26 |
PUSTULE |
1 |
0.0004 |
| 27 |
DERMAL CYST |
1 |
0.0004 |
| 28 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 29 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 30 |
SERUM SICKNESS |
1 |
0.0004 |
| 31 |
JOINT LOCK |
1 |
0.0004 |
| 32 |
BILIARY COLIC |
1 |
0.0003 |
| 33 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 34 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 35 |
HANGOVER |
1 |
0.0003 |
| 36 |
APPLICATION SITE REACTION |
2 |
0.0003 |
| 37 |
MACULOPATHY |
1 |
0.0003 |
| 38 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 39 |
HYPERACUSIS |
1 |
0.0003 |
| 40 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 41 |
BLEPHARITIS |
1 |
0.0002 |
| 42 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 43 |
SUBSTANCE ABUSE |
2 |
0.0002 |
| 44 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 45 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 46 |
APPLICATION SITE PAIN |
5 |
0.0002 |
| 47 |
INTENTIONAL DEVICE MISUSE |
1 |
0.0002 |
| 48 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 49 |
WHEELCHAIR USER |
1 |
0.0002 |
| 50 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 51 |
ROSACEA |
1 |
0.0002 |
| 52 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 53 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 54 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 55 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 56 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 57 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 58 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 59 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 60 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 61 |
NASAL DRYNESS |
1 |
0.0002 |
| 62 |
DYSMENORRHOEA |
2 |
0.0002 |
| 63 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 64 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 65 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 66 |
ACNE |
11 |
0.0001 |
| 67 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 68 |
PAPULE |
1 |
0.0001 |
| 69 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 70 |
SUNBURN |
1 |
0.0001 |
| 71 |
INSURANCE ISSUE |
2 |
0.0001 |
| 72 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 73 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 74 |
CONCUSSION |
1 |
0.0001 |
| 75 |
PELVIC FRACTURE |
1 |
0.0001 |
| 76 |
ABNORMAL FAECES |
1 |
0.0001 |
| 77 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 78 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 79 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 80 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 81 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 82 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 83 |
ABORTION INDUCED |
1 |
0.0001 |
| 84 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 85 |
COELIAC DISEASE |
1 |
0.0001 |
| 86 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 87 |
EMBEDDED DEVICE |
1 |
0.0001 |
| 88 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 89 |
DRY THROAT |
1 |
0.0001 |
| 90 |
FOLLICULITIS |
1 |
0.0001 |
| 91 |
SCRATCH |
1 |
0.0001 |
| 92 |
JOINT DISLOCATION |
1 |
0.0001 |
| 93 |
WOUND INFECTION |
1 |
0.0001 |
| 94 |
TOOTH DISORDER |
2 |
0.0001 |
| 95 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 96 |
SKIN INFECTION |
1 |
0.0001 |
| 97 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 98 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 99 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 100 |
SPINAL PAIN |
1 |
0.0001 |
| 101 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 102 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 103 |
NODULE |
1 |
0.0001 |
| 104 |
TOOTH INFECTION |
1 |
0.0001 |
| 105 |
EAR INFECTION |
2 |
0.0001 |
| 106 |
INJURY |
5 |
0.0001 |
| 107 |
BRONCHOSPASM |
1 |
0.0001 |
| 108 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 109 |
APATHY |
1 |
0.0001 |
| 110 |
COLITIS ULCERATIVE |
3 |
0.0001 |
| 111 |
SKIN IRRITATION |
3 |
0.0001 |
| 112 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 113 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 114 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 115 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 116 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 117 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 118 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 119 |
SCAR |
1 |
0.0001 |
| 120 |
LOCAL SWELLING |
1 |
0.0001 |
| 121 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 122 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 123 |
OSTEOMYELITIS |
1 |
0.0001 |
| 124 |
PHOTOPHOBIA |
1 |
0.0001 |
| 125 |
COLITIS |
2 |
0.0001 |
| 126 |
EAR PAIN |
1 |
0.0001 |
| 127 |
KIDNEY INFECTION |
1 |
0.0001 |
| 128 |
SINUS DISORDER |
1 |
0.0001 |
| 129 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 130 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 131 |
FLUSHING |
5 |
0.0000 |
| 132 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 133 |
SKIN CANCER |
1 |
0.0000 |
| 134 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 135 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 136 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 137 |
DRY SKIN |
6 |
0.0000 |
| 138 |
RASH PAPULAR |
1 |
0.0000 |
| 139 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 140 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 141 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 142 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 143 |
PRESYNCOPE |
1 |
0.0000 |
| 144 |
FLUID RETENTION |
2 |
0.0000 |
| 145 |
HYPOPHAGIA |
1 |
0.0000 |
| 146 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 147 |
RASH GENERALISED |
1 |
0.0000 |
| 148 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 149 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 150 |
JAUNDICE |
1 |
0.0000 |
| 151 |
RASH PRURITIC |
2 |
0.0000 |
| 152 |
LIMB INJURY |
1 |
0.0000 |
| 153 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 154 |
WOUND |
1 |
0.0000 |
| 155 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 156 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 157 |
EYE IRRITATION |
2 |
0.0000 |
| 158 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 159 |
NEEDLE ISSUE |
1 |
0.0000 |
| 160 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 161 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 162 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 163 |
FEELING HOT |
2 |
0.0000 |
| 164 |
HEAD INJURY |
1 |
0.0000 |
| 165 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 166 |
NIGHT SWEATS |
1 |
0.0000 |
| 167 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 168 |
SKIN DISORDER |
1 |
0.0000 |
| 169 |
EYE PRURITUS |
1 |
0.0000 |
| 170 |
ANGER |
1 |
0.0000 |
| 171 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 172 |
ERYTHEMA |
6 |
0.0000 |
| 173 |
BURNING SENSATION |
2 |
0.0000 |
| 174 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 175 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 176 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 177 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 178 |
EPISTAXIS |
2 |
0.0000 |
| 179 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 180 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 181 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 182 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 183 |
ANGIOEDEMA |
1 |
0.0000 |
| 184 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 185 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 186 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 187 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 188 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 189 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 190 |
MIGRAINE |
2 |
0.0000 |
| 191 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 192 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 193 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 194 |
DRY EYE |
1 |
0.0000 |
| 195 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 196 |
INFLAMMATION |
1 |
0.0000 |
| 197 |
SPEECH DISORDER |
1 |
0.0000 |
| 198 |
DEPRESSED MOOD |
1 |
0.0000 |
| 199 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 200 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 201 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 202 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 203 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 204 |
HERPES ZOSTER |
1 |
0.0000 |
| 205 |
LETHARGY |
1 |
0.0000 |
| 206 |
SURGERY |
1 |
0.0000 |
| 207 |
NASAL CONGESTION |
1 |
0.0000 |
| 208 |
IRRITABILITY |
1 |
0.0000 |
| 209 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 210 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 211 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 212 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 213 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 214 |
SWELLING FACE |
1 |
0.0000 |
| 215 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 216 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 217 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 218 |
WEIGHT DECREASED |
4 |
0.0000 |
| 219 |
MOBILITY DECREASED |
1 |
0.0000 |
| 220 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 221 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 222 |
DRUG INEFFECTIVE |
17 |
0.0000 |
| 223 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 224 |
HEADACHE |
8 |
0.0000 |
| 225 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 226 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 227 |
DRY MOUTH |
1 |
0.0000 |
| 228 |
TREATMENT FAILURE |
1 |
0.0000 |
| 229 |
DIZZINESS |
6 |
0.0000 |
| 230 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 231 |
URTICARIA |
2 |
0.0000 |
| 232 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 233 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 234 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 235 |
PAIN |
7 |
0.0000 |
| 236 |
TACHYCARDIA |
1 |
0.0000 |
| 237 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 238 |
DEVICE ISSUE |
1 |
0.0000 |
| 239 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 240 |
CHEST PAIN |
2 |
0.0000 |
| 241 |
NAUSEA |
8 |
0.0000 |
| 242 |
SINUSITIS |
1 |
0.0000 |
| 243 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 244 |
DIARRHOEA |
6 |
0.0000 |
| 245 |
RASH |
4 |
0.0000 |
| 246 |
CONSTIPATION |
2 |
0.0000 |
| 247 |
ASTHMA |
1 |
0.0000 |
| 248 |
DEPRESSION |
2 |
0.0000 |
| 249 |
PYREXIA |
3 |
0.0000 |
| 250 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 251 |
DECREASED APPETITE |
2 |
0.0000 |
| 252 |
CHILLS |
1 |
0.0000 |
| 253 |
PRURITUS |
3 |
0.0000 |
| 254 |
HYPERHIDROSIS |
1 |
0.0000 |
| 255 |
DEHYDRATION |
1 |
0.0000 |
| 256 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 257 |
VISION BLURRED |
1 |
0.0000 |
| 258 |
COUGH |
2 |
0.0000 |
| 259 |
ANXIETY |
2 |
0.0000 |
| 260 |
INFECTION |
1 |
0.0000 |
| 261 |
MALAISE |
3 |
0.0000 |
| 262 |
PARAESTHESIA |
1 |
0.0000 |
| 263 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 264 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 265 |
TREMOR |
1 |
0.0000 |
| 266 |
FALL |
2 |
0.0000 |
| 267 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 268 |
MUSCLE SPASMS |
1 |
0.0000 |
| 269 |
DYSPNOEA |
3 |
0.0000 |
| 270 |
ANAEMIA |
1 |
0.0000 |
| 271 |
HYPOTENSION |
1 |
0.0000 |
| 272 |
SOMNOLENCE |
1 |
0.0000 |
| 273 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 274 |
HYPERTENSION |
1 |
0.0000 |
| 275 |
OVERDOSE |
1 |
0.0000 |
| 276 |
OFF LABEL USE |
4 |
0.0000 |
| 277 |
WEIGHT INCREASED |
1 |
0.0000 |
| 278 |
VOMITING |
2 |
0.0000 |
| 279 |
FEELING ABNORMAL |
1 |
0.0000 |
| 280 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 281 |
FATIGUE |
3 |
0.0000 |
| 282 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 283 |
PNEUMONIA |
1 |
0.0000 |
| 284 |
ASTHENIA |
1 |
0.0000 |
| 285 |
ARTHRALGIA |
1 |
0.0000 |